HopeStage
Back to overview

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Topics
More filters
1326studies shown
Showing 1,081-1,092 of 1,326
Other study type icon
CompletedNCT07034313

Rouen Study on Anxiety

Official study title

Rouen Study on Anxiety During Allergy Tests

This study has finished and is no longer accepting participants.

In France
AnxietyObservational studyAges 18+
Countries
France
Sponsor
University Hospital, Rouen
Other study type icon
TerminatedNCT01717079

rTMS and Body Shape Perception

Official study title

Effect of Transcranial Magnetic Stimulation on Disturbance of Body Shape Perception in Patients With Anorexia Nervosa

This study ended early.

In France
Eating disordersPlacebo comparisonAges 18–80
Countries
France
Sponsor
University Hospital, Rouen
Drug study icon
CompletedNCT01295372

Safety and Efficacy of Zicronapine in people with Schizophrenia

What is this study about?

Researchers compared Zicronapine and Risperidone to find out how the approaches affected body weight in people with schizophrenia.

This study has finished and is no longer accepting participants.

In France
SchizophreniaMedication studyAges 18–65
Countries
France, Czechia, Estonia, + 2 others
Sponsor
H. Lundbeck A/S
Drug study icon
CompletedNCT00280566

Safety and Maintenance of Effect of Ziprasidone Plus a Mood Stabilizer in Bipolarity type I (Manic or Mixed)

Official study title

A Phase 3, Randomized, 6-Month, Double-Blind Trial in Subjects With Bipolar I Disorder to Evaluate the Continued Safety and Maintenance of Effect of Ziprasidone Plus a Mood Stabilizer (vs Placebo Plus a Mood Stabilizer) Following a Minimum of 2 Months of Response to Open-Label Treatment With Both Agents

This study has finished and is no longer accepting participants.

In France
BipolarityMedication studyAges 18+
Countries
France, United States, Chile, + 10 others
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Drug study icon
CompletedNCT03238326

Open-Label Flexible-dose Brexpiprazole for schizophrenia

What is this study about?

Researchers studied Brexpiprazole, tracking side effects to assess long-term safety and tolerability in young people with schizophrenia.

This study has finished and is no longer accepting participants.

In France
SchizophreniaMedication studyAges 13–17
Countries
France, United States, Italy, + 7 others
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
Drug study icon
CompletedNCT01922258

Flexible Dosing of Brexpiprazole for Mental health

Official study title

A Phase 3, 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Flexible Dosing of Brexpiprazole (OPC-34712) in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type

This study has finished and is no longer accepting participants.

In France
Mental healthMedication studyAges 55–90
Countries
France, United States, Canada, + 6 others
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
Other study type icon
CompletedNCT02192554

Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a study of Brexpiprazole or Placebo

Official study title

A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial

This study has finished and is no longer accepting participants.

In France
Mental healthObservational study
Countries
France, United States, Canada, + 9 others
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
Drug study icon
CompletedNCT00763438

Safety Study of an Antipsychotic, Sertindole, to Treat Schizophrenia

Official study title

A Prospective, Open-label, Single-arm, Multinational, Multi-centre, Flexible-dose, Extension Study of the SCoP 99824 With Sertindole for Patients Suffering From Schizophrenia

This study has finished and is no longer accepting participants.

In France
SchizophreniaMedication studyAges 18+
Countries
France
Sponsor
H. Lundbeck A/S
Drug study icon
CompletedNCT00271258

Safety Study of Sodium Divalproate in Bipolarity in Adolescents

Official study title

STUDY OF THE TOLERANCE OF SODIUM DIVALPROATE (DEPAKOTE) IN ADOLESCENTS IN MANIC, MIXED OR HYPOMANIC EPISODES OF BIPOLAR DISORDER

This study has finished and is no longer accepting participants.

In France
BipolarityMedication studyAges 13–18
Countries
France
Sponsor
Sanofi
Drug study icon
CompletedNCT00237913

Schizophrenia study of Aripiprazole

Official study title

A Multicenter, Randomized, Naturalistic, Open-Label Study Between Aripiprazole and Standard of Care in the Management of Community-Treated Schizophrenic Patients (Schizophrenia Trial of Aripiprazole - STAR)

This study has finished and is no longer accepting participants.

In France
SchizophreniaMedication studyAges 18–65
Countries
France, United Kingdom, Austria, + 6 others
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.